Interpace Biosciences, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2010 | $134.6M | $-6.9M | $-6.8M |
| FY2011 | $157.3M | $-4.7M | $-11.9M |
| FY2012 | $126.9M | $-25.2M | $-25.5M |
| FY2013 | $146.5M | $-1.4M | $-4.6M |
| FY2014 | $119.9M | $-17.8M | $-16.8M |
| FY2015 | $9.4M | $-40.4M | $-13.6M |
| FY2016 | $13.1M | $-6.4M | $-22.0M |
| FY2017 | $15.9M | $-6.3M | $12.6M |
| FY2018 | $21.9M | $-12.6M | $-12.7M |
| FY2019 | $24.2M | $-26.4M | $-26.7M |
| FY2020 | $32.4M | $-26.1M | $-26.5M |
| FY2021 | $8.2M | $-6.3M | $-14.9M |
| FY2022 | $5.7M | $-3.6M | $-22.0M |
| FY2023 | $40.0M | $4.0M | $2.0M |
| FY2024 | $46.9M | $8.1M | $6.7M |
| FY2025 | $38.7M | $4.1M | $24.6M |